(ASML) ASML Holding - Overview
Exchange: NASDAQ •
Country: Netherlands •
Currency: USD •
Type: Common Stock •
ISIN: USN070592100
Stock: Lithography, Metrology, Inspection, Upgrade, Service
Total Rating 78
Risk 99
Buy Signal 0.09
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.95% |
| Yield on Cost 5y | 2.25% |
| Yield CAGR 5y | 16.85% |
| Payout Consistency | 84.9% |
| Payout Ratio | 23.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 43.4% |
| Relative Tail Risk | -6.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.70 |
| Alpha | 71.18 |
| Character TTM | |
|---|---|
| Beta | 1.457 |
| Beta Downside | 1.238 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.48% |
| CAGR/Max DD | 0.67 |
Description: ASML ASML Holding February 05, 2026
ASML Holding N.V. designs, manufactures, and services advanced lithography equipment that enables semiconductor manufacturers to print circuit patterns onto wafers. Its portfolio spans extreme-ultraviolet (EUV) systems, deep-ultraviolet (DUV) immersion and dry tools, metrology and inspection solutions (e.g., YieldStar optical metrology, HMI electron-beam defect analysis), and computational lithography software, together with refurbishment, upgrades, and customer support worldwide.
Key recent metrics (Q2 2024): Revenue reached €7.0 billion, up 14 % YoY, driven by a 22 % increase in EUV system shipments (27 units) and a record order backlog of €40 billion, reflecting strong demand from AI-focused fab expansions in the United States and Taiwan. R&D intensity remains high at ~15 % of revenue, supporting a 45 % market-share lead in EUV lithography. Macro-level drivers include the global push for advanced nodes (5 nm and below) and government incentives for domestic chip production, which together sustain ASML’s pricing power but expose the company to cyclical fab-capacity utilization risks.
For a deeper, data-driven look at ASML’s valuation and risk profile, see the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 9.85b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 14.28 > 1.0 |
| NWC/Revenue: 18.38% < 20% (prev 33.66%; Δ -15.28% < -1%) |
| CFO/TA 0.26 > 3% & CFO 11.88b > Net Income 9.85b |
| Net Debt (-2.42b) to EBITDA (13.25b): -0.18 < 3 |
| Current Ratio: 1.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (387.6m) vs 12m ago -1.52% < -2% |
| Gross Margin: 52.44% > 18% (prev 0.51%; Δ 5193 % > 0.5%) |
| Asset Turnover: 74.20% > 50% (prev 62.87%; Δ 11.33% > 0%) |
| Interest Coverage Ratio: 954.1 > 6 (EBITDA TTM 13.25b / Interest Expense TTM 12.7m) |
Altman Z'' 4.54
| A: 0.13 (Total Current Assets 25.15b - Total Current Liabilities 19.22b) / Total Assets 45.10b |
| B: 0.32 (Retained Earnings 14.41b / Total Assets 45.10b) |
| C: 0.28 (EBIT TTM 12.12b / Avg Total Assets 43.41b) |
| D: 0.73 (Book Value of Equity 18.99b / Total Liabilities 26.10b) |
| Altman-Z'' Score: 4.54 = AA |
Beneish M -3.04
| DSRI: 0.82 (Receivables 6.70b/6.67b, Revenue 32.21b/26.24b) |
| GMI: 0.98 (GM 52.44% / 51.15%) |
| AQI: 1.07 (AQ_t 0.26 / AQ_t-1 0.25) |
| SGI: 1.23 (Revenue 32.21b / 26.24b) |
| TATA: -0.04 (NI 9.85b - CFO 11.88b) / TA 45.10b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of ASML shares?
As of February 07, 2026, the stock is trading at USD 1413.01 with a total of 1,891,604 shares traded.
Over the past week, the price has changed by -0.70%, over one month by +13.75%, over three months by +37.29% and over the past year by +93.00%.
Over the past week, the price has changed by -0.70%, over one month by +13.75%, over three months by +37.29% and over the past year by +93.00%.
Is ASML a buy, sell or hold?
ASML Holding has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy ASML.
- StrongBuy: 22
- Buy: 8
- Hold: 9
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the ASML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1470.8 | 4.1% |
| Analysts Target Price | 1470.8 | 4.1% |
| ValueRay Target Price | 1855.9 | 31.3% |
ASML Fundamental Data Overview January 31, 2026
Market Cap EUR = 478.89b (565.40b USD * 0.847 USD.EUR)
P/E Trailing = 49.3111
P/E Forward = 42.9185
P/S = 17.3077
P/B = 23.9666
P/EG = 2.434
Revenue TTM = 32.21b EUR
EBIT TTM = 12.12b EUR
EBITDA TTM = 13.25b EUR
Long Term Debt = 2.70b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.08b EUR (from shortTermDebt, last fiscal year)
Debt = 2.70b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.42b EUR (from netDebt column, last quarter)
Enterprise Value = 476.47b EUR (478.89b + Debt 2.70b - CCE 5.13b)
Interest Coverage Ratio = 954.1 (Ebit TTM 12.12b / Interest Expense TTM 12.7m)
EV/FCF = 50.44x (Enterprise Value 476.47b / FCF TTM 9.45b)
FCF Yield = 1.98% (FCF TTM 9.45b / Enterprise Value 476.47b)
FCF Margin = 29.32% (FCF TTM 9.45b / Revenue TTM 32.21b)
Net Margin = 30.58% (Net Income TTM 9.85b / Revenue TTM 32.21b)
Gross Margin = 52.44% ((Revenue TTM 32.21b - Cost of Revenue TTM 15.32b) / Revenue TTM)
Gross Margin QoQ = 51.63% (prev 52.57%)
Tobins Q-Ratio = 10.57 (Enterprise Value 476.47b / Total Assets 45.10b)
Interest Expense / Debt = 0.47% (Interest Expense 12.7m / Debt 2.70b)
Taxrate = 17.23% (442.2m / 2.57b)
NOPAT = 10.03b (EBIT 12.12b * (1 - 17.23%))
Current Ratio = 1.31 (Total Current Assets 25.15b / Total Current Liabilities 19.22b)
Debt / Equity = 0.14 (Debt 2.70b / totalStockholderEquity, last quarter 18.99b)
Debt / EBITDA = -0.18 (Net Debt -2.42b / EBITDA 13.25b)
Debt / FCF = -0.26 (Net Debt -2.42b / FCF TTM 9.45b)
Total Stockholder Equity = 18.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.69% (Net Income 9.85b / Total Assets 45.10b)
RoE = 54.27% (Net Income TTM 9.85b / Total Stockholder Equity 18.15b)
RoCE = 58.11% (EBIT 12.12b / Capital Employed (Equity 18.15b + L.T.Debt 2.70b))
RoIC = 120.7% (NOPAT 10.03b / Invested Capital 8.31b)
WACC = 11.22% (E(478.89b)/V(481.59b) * Re(11.28%) + D(2.70b)/V(481.59b) * Rd(0.47%) * (1-Tc(0.17)))
Discount Rate = 11.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.79%
[DCF Debug] Terminal Value 59.91% ; FCFF base≈6.78b ; Y1≈4.91b ; Y5≈2.73b
Fair Price DCF = 91.57 (EV 33.12b - Net Debt -2.42b = Equity 35.54b / Shares 388.1m; r=11.22% [WACC]; 5y FCF grow -32.47% → 2.90% )
[DCF Warning] FCF declining rapidly (-32.47%), DCF may be unreliable
EPS Correlation: 64.40 | EPS CAGR: 42.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: 74.84 | Revenue CAGR: 11.57% | SUE: -0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=6.65 | Chg30d=+1.114 | Revisions Net=+3 | Analysts=14
EPS current Year (2026-12-31): EPS=29.13 | Chg30d=+3.223 | Revisions Net=+16 | Growth EPS=+17.9% | Growth Revenue=+12.8%
EPS next Year (2027-12-31): EPS=36.37 | Chg30d=+4.710 | Revisions Net=+13 | Growth EPS=+24.9% | Growth Revenue=+16.7%
P/E Trailing = 49.3111
P/E Forward = 42.9185
P/S = 17.3077
P/B = 23.9666
P/EG = 2.434
Revenue TTM = 32.21b EUR
EBIT TTM = 12.12b EUR
EBITDA TTM = 13.25b EUR
Long Term Debt = 2.70b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.08b EUR (from shortTermDebt, last fiscal year)
Debt = 2.70b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.42b EUR (from netDebt column, last quarter)
Enterprise Value = 476.47b EUR (478.89b + Debt 2.70b - CCE 5.13b)
Interest Coverage Ratio = 954.1 (Ebit TTM 12.12b / Interest Expense TTM 12.7m)
EV/FCF = 50.44x (Enterprise Value 476.47b / FCF TTM 9.45b)
FCF Yield = 1.98% (FCF TTM 9.45b / Enterprise Value 476.47b)
FCF Margin = 29.32% (FCF TTM 9.45b / Revenue TTM 32.21b)
Net Margin = 30.58% (Net Income TTM 9.85b / Revenue TTM 32.21b)
Gross Margin = 52.44% ((Revenue TTM 32.21b - Cost of Revenue TTM 15.32b) / Revenue TTM)
Gross Margin QoQ = 51.63% (prev 52.57%)
Tobins Q-Ratio = 10.57 (Enterprise Value 476.47b / Total Assets 45.10b)
Interest Expense / Debt = 0.47% (Interest Expense 12.7m / Debt 2.70b)
Taxrate = 17.23% (442.2m / 2.57b)
NOPAT = 10.03b (EBIT 12.12b * (1 - 17.23%))
Current Ratio = 1.31 (Total Current Assets 25.15b / Total Current Liabilities 19.22b)
Debt / Equity = 0.14 (Debt 2.70b / totalStockholderEquity, last quarter 18.99b)
Debt / EBITDA = -0.18 (Net Debt -2.42b / EBITDA 13.25b)
Debt / FCF = -0.26 (Net Debt -2.42b / FCF TTM 9.45b)
Total Stockholder Equity = 18.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.69% (Net Income 9.85b / Total Assets 45.10b)
RoE = 54.27% (Net Income TTM 9.85b / Total Stockholder Equity 18.15b)
RoCE = 58.11% (EBIT 12.12b / Capital Employed (Equity 18.15b + L.T.Debt 2.70b))
RoIC = 120.7% (NOPAT 10.03b / Invested Capital 8.31b)
WACC = 11.22% (E(478.89b)/V(481.59b) * Re(11.28%) + D(2.70b)/V(481.59b) * Rd(0.47%) * (1-Tc(0.17)))
Discount Rate = 11.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.79%
[DCF Debug] Terminal Value 59.91% ; FCFF base≈6.78b ; Y1≈4.91b ; Y5≈2.73b
Fair Price DCF = 91.57 (EV 33.12b - Net Debt -2.42b = Equity 35.54b / Shares 388.1m; r=11.22% [WACC]; 5y FCF grow -32.47% → 2.90% )
[DCF Warning] FCF declining rapidly (-32.47%), DCF may be unreliable
EPS Correlation: 64.40 | EPS CAGR: 42.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: 74.84 | Revenue CAGR: 11.57% | SUE: -0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=6.65 | Chg30d=+1.114 | Revisions Net=+3 | Analysts=14
EPS current Year (2026-12-31): EPS=29.13 | Chg30d=+3.223 | Revisions Net=+16 | Growth EPS=+17.9% | Growth Revenue=+12.8%
EPS next Year (2027-12-31): EPS=36.37 | Chg30d=+4.710 | Revisions Net=+13 | Growth EPS=+24.9% | Growth Revenue=+16.7%